Search

Your search keyword '"Callegaro, Dagoberto"' showing total 424 results
Start Over Author "Callegaro, Dagoberto"
424 results on '"Callegaro, Dagoberto"'

3. Real-world application of the 2022 diagnostic criteria for first-ever episode of optic neuritis

Author

Terrim, Sara, Silva, Guilherme Diogo, de Sá e Benevides Falcao, Fernando Cavalcanti, dos Reis Pereira, Clarissa, de Souza Andrade Benassi, Thais, Fortini, Ida, Gonçalves, Marcia Rubia Rodrigues, Castro, Luiz Henrique Martins, Comerlatti, Luiz Roberto, de Medeiros Rimkus, Carolina, Adoni, Tarso, Pereira, Samira Luisa Apostolos, Monteiro, Mário Luiz, and Callegaro, Dagoberto

Published
2023
Full Text
View/download PDF

4. A comparative study of visual outcome in patients with optic neuritis treated with five or seven days of intravenous corticosteroid treatment

Author

Silva, Guilherme Diogo, Terrim, Sara, Falcão, Fernando Cavalcantide Sá e Benevides, Falcão, Maria Alice Pimentel, Chaves, Cleuber Esteves, Apóstolos-Pereira, Samira, Fortini, Ida, Gonçalves, Márcia Rúbia Rodrigues, Comerlatti, Luiz Roberto, Castro, Luiz Henrique Martins, Callegaro, Dagoberto, and Monteiro, Mário Luiz Ribeiro

Published
2023
Full Text
View/download PDF

11. Application of NMOSD IPND-2015 Criteria in AQP4-IgG Positive, MOG-IgG Positive and Seronegative Inflammatory Demyelinating Diseases (P10-14.004)

Author

Apostolos-Pereira, Samira, primary, Oliveira, João Vitor Mahler Ferreira, additional, Silva, Guilherme Diogo, additional, Schoeps, Vinicius, additional, Gomes, Ana Beatriz Ayroza Galvao Ribeiro, additional, Mendes, Natalia, additional, Matos, Aline, additional, Solti, Marina, additional, Torretta, Pedro Henrique, additional, Pitombeira, Milena, additional, de Olivei, Mateus Boaventura, additional, Paolilo, Renata, additional, Rimkus, Carolina, additional, Adoni, Tarso, additional, Proebstel, Anne-Katrin, additional, Sato, Douglas, additional, and Callegaro, Dagoberto, additional

Published
2024
Full Text
View/download PDF

15. Patients and neurologists have different perceptions of multiple sclerosis symptoms, care and challenges

Author

Marin, Cássia Elisa, Kfouri, Paula Prado, Callegaro, Dagoberto, Lana-Peixoto, Marco Aurélio, Neto, Antonio Pereira Gomes, Vasconcelos, Claudia Cristina Ferreira, d'Almeida, José Artur Costa, Gonçalves, Marcus Vinícius Magno, Mendes, Maria Fernanda, Parolin, Mônica Koncke Fiuza, Nascimento, Osvaldo, da Gama, Paulo Diniz, Dias-Carneiro, Rafael Paternò Castello, Dias, Ronaldo Maciel, Damasceno, Alfredo, San Martin, Gustavo, and Becker, Jefferson

Published
2021
Full Text
View/download PDF

16. Tongue pressure is a strong predictor of recommendation for gastrostomy in amyotrophic lateral sclerosis.

Author

Mendes, Amanda E., Silva, Guilherme D., Jorge, Frederico M. H., and Callegaro, Dagoberto

Abstract

Introduction/Aims: Objective and practical biomarkers to determine the need for gastrostomy in patients with amyotrophic lateral sclerosis (ALS) are lacking. Tongue pressure (TP) is a promising biomarker because it is associated with bulbar dysfunction. The aims of this study were to evaluate the association of TP with the need for gastrostomy, and to determine its optimal cut‐off value. Methods: This prospective observational study included participants with ALS taking nutrition orally. TP was evaluated using the Iowa Oral Performance Instrument. Need for gastrostomy as determined by a multidisciplinary team during a 12‐month follow up period was recorded. Associations between TP and need for gastrostomy placement were performed. ROC curve analysis determined the optimal cut‐off value of TP to predict gastrostomy. Results: Of 208 screened participants, 119 were included. Gastrostomy was indicated in 45% (53), in a 12‐month follow up period. TP of ≤20 kPA was a strong predictor of gastrostomy indication (OR 11.8, CI 95% [4.61, 34.7], p <.001). The association persisted even after adjustment for weight loss, pneumonia, prolonged feeding duration, Revised ALS Functional Rating Scale score, and American Speech‐Language‐Hearing Association scale score (OR 4.51, CI 95% [1.50, 14.9], p =.009). By receiver operating characteristic curve analysis, 20 kPA represented the optimal cut‐off value (sensitivity 0.75, specificity 0.89). Discussion: TP is a strong independent predictor of gastrostomy indication in the subsequent 12 months in patients with ALS, with good sensitivity and specificity at a cutoff value of ≤20 kPA, suggesting that it may be a promising biomarker in clinical practice. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

17. Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients

Author

Whittam, Daniel H, Cobo-Calvo, Alvaro, Lopez-Chiriboga, A Sebastian, Pardo, Santiago, Gornall, Matthew, Cicconi, Silvia, Brandt, Alexander, Berek, Klaus, Berger, Thomas, Jelcic, Ilijas, Gombolay, Grace, Oliveira, Luana Micheli, Callegaro, Dagoberto, Kaneko, Kimihiko, Misu, Tatsuro, Capobianco, Marco, Gibbons, Emily, Karthikeayan, Venkatraman, Brochet, Bruno, Audoin, Bertrand, Mathey, Guillaume, Laplaud, David, Thouvenot, Eric, Cohen, Mikaël, Tourbah, Ayman, Maillart, Elisabeth, Ciron, Jonathan, Deschamps, Romain, Biotti, Damien, Rostasy, Kevin, Neuteboom, Rinze, Hemingway, Cheryl, Forsyth, Rob, Matiello, Marcelo, Webb, Stewart, Hunt, David, Murray, Katy, Hacohen, Yael, Lim, Ming, Leite, M Isabel, Palace, Jacqueline, Solomon, Tom, Lutterotti, Andreas, Fujihara, Kazuo, Nakashima, Ichiro, Bennett, Jeffrey L, Pandit, Lekha, Chitnis, Tanuja, Weinshenker, Brian G, Wildemann, Brigitte, Sato, Douglas Kazutoshi, Kim, Su-Hyun, Huda, Saif, Kim, Ho Jin, Reindl, Markus, Levy, Michael, Jarius, Sven, Tenembaum, Silvia, Paul, Friedemann, Pittock, Sean, Marignier, Romain, and Jacob, Anu

Published
2020
Full Text
View/download PDF

20. Clinical Features of COVID-19 on Patients With Neuromyelitis Optica Spectrum Disorders

Author

Apostolos-Pereira, Samira Luisa, Campos Ferreira, Lis, Boaventura, Mateus, de Carvalho Sousa, Nise Alessandra, Joca Martins, Gabriela, dʼAlmeida, José Arthur, Pitombeira, Milena, Silvestre Mendes, Lucas, Fukuda, Thiago, Souza Cabeça, Hideraldo Luíz, Chaves Rocha, Luciano, Santos de Oliveira, Bianca, Vieira Stella, Carla Renata, Lobato de Oliveira, Enedina Maria, de Souza Amorim, Leizian, Ferrari de Castro, Andréa, Pereira Gomes Neto, Antonio, Diogo Silva, Guilherme, Bueno, Lucas, de Morais Machado, Maria, Castello Dias-Carneiro, Rafael, Maciel Dias, Ronaldo, Porto Moreira, Alvaro, Piccolo, Ana, Kuntz Grzesiuk, Anderson, Muniz, Andre, Diniz Disserol, Caio, Ferreira Vasconcelos, Claudia, Kaimen-Maciel, Damacio, Sisterolli Diniz, Denise, Comini-Frota, Elizabeth, Coronetti Rocha, Fernando, Cruz dos Santos, Gutemberg Augusto, Dadalti Fragoso, Yara, Sciascia do Olival, Guilherme, Ruocco, Heloisa Helena, Siqueira, Heloise Helena, Sato, Henry Koity, Figueiredo, José Alexandre, Jr, Cortoni Calia, Leandro, Teixeira Dourado, Mario Emilio, Jr, Scolari, Letícia, Ribeiro Soares Neto, Herval, Melges, Luiz, Magno Gonçalves, Marcus Vinicius, Vellutini Pimentel, Maria Lucia, de Castro Ribeiro, Marlise, Gurrola Arambula, Omar, Diniz da Gama, Paulo, Leite Menon, Renata, Barbosa Thomaz, Rodrigo, de Rizo Morales, Rogério, Sobreira, Silvana, Machado, Suzana Nunes, Gonsalves Jubé Ribeiro, Taysa, Coelho Santa Rita Pereira, Valéria, Maia Costa, Vanessa, da Nóbrega Junior, Adaucto Wanderley, Vieira Alves-Leon, Soniza, Mamprim de Morais Perin, Marilia, Donadi, Eduardo, Adoni, Tarso, Gomes, Sidney, Brito Ferreira, Maria, Callegaro, Dagoberto, Mendes, Maria Fernanda, Brum, Doralina, and von Glehn, Felipe

Published
2021
Full Text
View/download PDF

21. Misdiagnosis in multiple sclerosis in a Brazilian reference center: Clinical, radiological, laboratory profile and failures in the diagnostic process—Cohort study

Author

Tieppo, Eduardo Macedo de Souza, primary, Silva, Guilherme Diogo, additional, Silva, Tomás Fraga Ferreira da, additional, Araujo, Roger Santana de, additional, Oliveira, Mateus Boaventura de, additional, Spricigo, Mariana Gondim Peixoto, additional, Pimentel, Gabriela Almeida, additional, Campana, Igor Gusmão, additional, Castrillo, Bruno Batitucci, additional, Mendes, Natalia Trombini, additional, Teixeira, Larissa Silva, additional, Nunes, Douglas Mendes, additional, Rimkus, Carolina de Medeiros, additional, Adoni, Tarso, additional, Apóstolos Pereira, Samira Luisa, additional, and Callegaro, Dagoberto, additional

Published
2023
Full Text
View/download PDF

23. Immunoglobulin A Antibodies Against Myelin Oligodendrocyte Glycoprotein in a Subgroup of Patients With Central Nervous System Demyelination

Author

Ayroza Galvão Ribeiro Gomes, Ana Beatriz, primary, Kulsvehagen, Laila, additional, Lipps, Patrick, additional, Cagol, Alessandro, additional, Cerdá-Fuertes, Nuria, additional, Neziraj, Tradite, additional, Flammer, Julia, additional, Lerner, Jasmine, additional, Lecourt, Anne-Catherine, additional, de Oliveira S. Siebenborn, Nina, additional, Cortese, Rosa, additional, Schaedelin, Sabine, additional, Andreoli Schoeps, Vinicius, additional, de Moura Brasil Matos, Aline, additional, Trombini Mendes, Natalia, additional, dos Reis Pereira, Clarissa, additional, Ribeiro Monteiro, Mario Luiz, additional, dos Apóstolos-Pereira, Samira Luisa, additional, Schindler, Patrick, additional, Chien, Claudia, additional, Schwake, Carolin, additional, Schneider, Ruth, additional, Pakeerathan, Thivya, additional, Aktas, Orhan, additional, Fischer, Urs, additional, Mehling, Matthias, additional, Derfuss, Tobias, additional, Kappos, Ludwig, additional, Ayzenberg, Ilya, additional, Ringelstein, Marius, additional, Paul, Friedemann, additional, Callegaro, Dagoberto, additional, Kuhle, Jens, additional, Papadopoulou, Athina, additional, Granziera, Cristina, additional, and Pröbstel, Anne-Katrin, additional

Published
2023
Full Text
View/download PDF

24. AQP4-IgG NMOSD, MOGAD, and double-seronegative NMOSD: is it possible to depict the antibody subtype using magnetic resonance imaging?

Author

Fragoso, Diego Cardoso, Salles, Luana Michelli Oliveira de Paula, Pereira, Samira Luisa Apóstolos, Callegaro, Dagoberto, Sato, Douglas Kazutoshi, and Rimkus, Carolina de Medeiros

Subjects
Neuromielite Óptica, Neuromyelitis Optica, Myelin-Oligodendrocyte Glycoprotein, Imageamento por Ressonância Magnética, Magnetic Resonance Imaging, Glicoproteína Mielina-Oligodendrócito
Abstract

Background There is clinical and radiological overlap among demyelinating diseases. However, their pathophysiological mechanisms are different and carry distinct prognoses and treatment demands. Objective To investigate magnetic resonance imaging (MRI) features of patients with myelin-oligodendrocyte glycoprotein associated disease (MOGAD), antibody against aquaporin-4(AQP-4)-immunoglobulin G-positive neuromyelitis optica spectrum disorder (AQP4-IgG NMOSD), and double-seronegative patients. Methods A cross-sectional retrospective study was performed to analyze the topography and morphology of central nervous system (CNS) lesions. Two neuroradiologists consensually analyzed the brain, orbit, and spinal cord images. Results In total, 68 patients were enrolled in the study (25 with AQP4-IgG-positive NMOSD, 28 with MOGAD, and 15 double-seronegative patients). There were differences in clinical presentation among the groups. The MOGAD group had less brain involvement (39.2%) than the NMOSD group (p = 0.002), mostly in the subcortical/juxtacortical, the midbrain, the middle cerebellar peduncle, and the cerebellum. Double-seronegative patients had more brain involvement (80%) with larger and tumefactive lesion morphology. In addition, double-seronegative patients showed the longest optic neuritis (p = 0.006), which was more prevalent in the intracranial optic nerve compartment. AQP4-IgG-positive NMOSD optic neuritis had a predominant optic-chiasm location, and brain lesions mainly affected hypothalamic regions and the postrema area (MOGAD versus AQP4-IgG-positive NMOSD, p= 0 .013). Furthermore, this group had more spinal cord lesions (78.3%), and bright spotty lesions were a paramount finding to differentiate it from MOGAD (p = 0.003). Conclusion The pooled analysis of lesion topography, morphology, and signal intensity provides critical information to help clinicians form a timely differential diagnosis. Resumo Antecedentes Há sobreposição clínica e radiológica entre as doenças desmielinizantes. No entanto, seus mecanismos fisiopatológicos são diferentes e apresentam prognósticos e demandas de tratamento distintos. Objetivo Investigar as características de imagens de RM dos pacientes com doença associada à glicoproteína de oligodendrócito de mielina (MOGAD), a doenças do espectro da neuromielite óptica positivas para antiaquaporina-4 imunoglobulina G (AQP4-IgG NMOSD), e pacientes duplamente soronegativos. Métodos Estudo retrospectivo e transversal para analisar as características e frequência das lesões do sistema nervoso central (SNC). Dois neurorradiologistas avaliaram consensualmente as imagens do cérebro, das órbitas e da medula espinhal. Resultados Ao todo, foram incluídos 68 pacientes(25 com AQP4-IgG NMOSD, 28 com MOGAD e 15 duplo-soronegativos). Há diferenças na apresentação clínica entre os grupos. O grupo MOGAD demonstrou menor frequência de comprometimento do cérebro (39.2%) comparado com o AQP4-IgG NMOSD (p = 0.002), com predomínio da distribuição das lesões nas regiões subcortical/justacortical, mesencéfalo, pedúnculos cerebelares médios e cerebelo. O grupo duplo-soronegativo demonstrou maior frequência de comprometimento do cérebro (80%), com lesões de maiores dimensões e com morfologia tumefeita, além de neurite óptica com maior extensão (p = 0.006). O grupo AQP4-IgG NMOSD demonstrou neurite óptica com predomínio na região óptico-quiasmática e as lesões encefálicas acometeram predominantemente as regiões hipotalâmica e área postrema (MOGAD versus AQP4-IgG NMOSD p = 0.013). Além disso, foram observadas mais lesões na medula espinhal (78.3%) e a presença da “bright spotty lesion” foi um achado primordial para a sua diferenciação com os pacientes MOGAD (p = 0.003). Conclusão A análise pormenorizada das características das lesões por RM dos pacientes com doenças desmielinizantes imunomediadas fornece informações fundamentais que auxiliam os médicos no diagnóstico diferencial em um momento oportuno.

Published
2023

28. Paracentral Acute Middle Maculopathy Associated with Severe Anti-Mog (Myelin Oligodendrocyte Glycoprotein)-Positive Optic Neuritis

Author

Fernandes, Rodrigo Dahia, primary, de Souza Andrade, Thais, additional, Preti, Rony C., additional, Zacharias, Leandro C., additional, Silva, Guilherme Diogo, additional, Lucato, Leandro Tavares, additional, Apóstolos-Pereira, Samira L., additional, Callegaro, Dagoberto, additional, and Monteiro, Mário Luiz R., additional

Published
2023
Full Text
View/download PDF

32. Reducing infection risk in multiple sclerosis and neuromyelitis optica spectrum disorders: a Brazilian reference center's approach

Author

Gomes, Ana Beatriz Ayroza Galvão Ribeiro, additional, Feo, Lucas Bueno, additional, Silva, Guilherme Diogo, additional, Disserol, Caio César Diniz, additional, Paolilo, Renata Barbosa, additional, Lara, Amanda Nazareth, additional, Tonácio, Adriana Coracini, additional, Mendes, Maria Fernanda, additional, Pereira, Samira Luísa Apóstolos, additional, and Callegaro, Dagoberto, additional

Published
2022
Full Text
View/download PDF

38. Season of birth as a risk factor for multiple sclerosis in Brazil

Author

Becker, Jefferson, Callegaro, Dagoberto, Lana-Peixoto, Marco Aurélio, Ferreira, Maria Lúcia B., Melo, Ailton, Diniz da Gama, Paulo, Souza, Doralina G.B., Teixeira, Carlos A.C., Kaimen-Maciel, Damacio Ramón, Gonçalves, Marcus Vinícius, Matta, André P.C., Abraham, Ronaldo, Furtado, Luís Edmundo T.A., Lino, Angelina, Hauck, Laura, Barreira, Amilton Antunes, and Gomes, Irenio

Published
2013
Full Text
View/download PDF

41. AQP4-IgG NMOSD, MOGAD, and double-seronegative NMOSD: is it possible to depict the antibody subtype using magnetic resonance imaging?

Author

Cardoso Fragoso, Diego, Oliveira de Paula Salles, Luana Michelli, Apóstolos Pereira, Samira Luisa, Callegaro, Dagoberto, Douglas Kazutoshi Sato, and de Medeiros Rimkus, Carolina

Abstract

Copyright of Arquivos de Neuro-Psiquiatria is the property of Thieme Medical Publishing Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2023
Full Text
View/download PDF

42. Clinical and MRI measures to identify non-acute MOG-antibody disease in adults.

Author

Cortese, Rosa, Battaglini, Marco, Prados, Ferran, Bianchi, Alessia, Haider, Lukas, Jacob, Anu, Palace, Jacqueline, Messina, Silvia, Paul, Friedemann, Wuerfel, Jens, Marignier, Romain, Durand-Dubief, Françoise, Rimkus, Carolina de Medeiros, Callegaro, Dagoberto, Sato, Douglas Kazutoshi, Filippi, Massimo, Rocca, Maria Assunta, Cacciaguerra, Laura, Rovira, Alex, and Sastre-Garriga, Jaume

Subjects
NEUROMYELITIS optica, MYELIN oligodendrocyte glycoprotein, AQUAPORINS, MAGNETIC resonance imaging, CERVICAL cord, BRAIN damage
Abstract

MRI and clinical features of myelin oligodendrocyte glycoprotein (MOG)-antibody disease may overlap with those of other inflammatory demyelinating conditions posing diagnostic challenges, especially in non-acute phases and when serologic testing for MOG antibodies is unavailable or shows uncertain results. We aimed to identify MRI and clinical markers that differentiate non-acute MOG-antibody disease from aquaporin 4 (AQP4)-antibody neuromyelitis optica spectrum disorder and relapsing remitting multiple sclerosis, guiding in the identification of patients with MOG-antibody disease in clinical practice. In this cross-sectional retrospective study, data from 16 MAGNIMS centres were included. Data collection and analyses were conducted from 2019 to 2021. Inclusion criteria were: diagnosis of MOG-antibody disease; AQP4-neuromyelitis optica spectrum disorder and multiple sclerosis; brain and cord MRI at least 6 months from relapse; and Expanded Disability Status Scale (EDSS) score on the day of MRI. Brain white matter T2 lesions, T1-hypointense lesions, cortical and cord lesions were identified. Random forest models were constructed to classify patients as MOG-antibody disease/AQP4-neuromyelitis optica spectrum disorder/multiple sclerosis; a leave one out cross-validation procedure assessed the performance of the models. Based on the best discriminators between diseases, we proposed a guide to target investigations for MOG-antibody disease. One hundred and sixty-two patients with MOG-antibody disease [99 females, mean age: 41 (±14) years, median EDSS: 2 (0–7.5)], 162 with AQP4-neuromyelitis optica spectrum disorder [132 females, mean age: 51 (±14) years, median EDSS: 3.5 (0–8)], 189 with multiple sclerosis (132 females, mean age: 40 (±10) years, median EDSS: 2 (0–8)] and 152 healthy controls (91 females) were studied. In young patients (<34 years), with low disability (EDSS < 3), the absence of Dawson's fingers, temporal lobe lesions and longitudinally extensive lesions in the cervical cord pointed towards a diagnosis of MOG-antibody disease instead of the other two diseases (accuracy: 76%, sensitivity: 81%, specificity: 84%, P < 0.001). In these non-acute patients, the number of brain lesions < 6 predicted MOG-antibody disease versus multiple sclerosis (accuracy: 83%, sensitivity: 82%, specificity: 83%, P < 0.001). An EDSS < 3 and the absence of longitudinally extensive lesions in the cervical cord predicted MOG-antibody disease versus AQP4-neuromyelitis optica spectrum disorder (accuracy: 76%, sensitivity: 89%, specificity: 62%, P < 0.001). A workflow with sequential tests and supporting features is proposed to guide better identification of patients with MOG-antibody disease. Adult patients with non-acute MOG-antibody disease showed distinctive clinical and MRI features when compared to AQP4-neuromyelitis optica spectrum disorder and multiple sclerosis. A careful inspection of the morphology of brain and cord lesions together with clinical information can guide further analyses towards the diagnosis of MOG-antibody disease in clinical practice. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

43. Recommendations by the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology (DCNI/ABN) and the Brazilian Committee for Treatment and Research in Multiple Sclerosis and Neuroimmunological Diseases (BCTRIMS) on vaccination in general and specifically against SARS-CoV-2 for patients with demyelinating diseases of the central nervous system

Author

Becker, Jefferson, Ferreira, Lis Campos, Damasceno, Alfredo, Bichuetti, Denis Bernardi, Christo, Paulo Pereira, Callegaro, Dagoberto, Peixoto, Marco Aurélio Lana, Sousa, Nise Alessandra De Carvalho, Almeida, Sérgio Monteiro De, Adoni, Tarso, Santiago-Amaral, Juliana, Junqueira, Thiago, Pereira, Samira Luisa Apóstolos, Gomes, Ana Beatriz Ayroza Galvão Ribeiro, Pitombeira, Milena, Paolilo, Renata Barbosa, Grzesiuk, Anderson Kuntz, Piccolo, Ana Claudia, D´Almeida, José Arthur Costa, Gomes Neto, Antonio Pereira, Oliveira, Augusto Cesar Penalva De, Oliveira, Bianca Santos De, Tauil, Carlos Bernardo, Vasconcelos, Claudia Ferreira, Kaimen-Maciel, Damacio, Varela, Daniel, Diniz, Denise Sisterolli, Oliveira, Enedina Maria Lobato De, Malfetano, Fabiola Rachid, Borges, Fernando Elias, Figueira, Fernando Faria Andrade, Gondim, Francisco De Assis Aquino, Passos, Giordani Rodrigues Dos, Silva, Guilherme Diogo, Olival, Guilherme Sciascia Do, Santos, Gutemberg Augusto Cruz Dos, Ruocco, Heloisa Helena, Sato, Henry Koiti, Soares Neto, Herval Ribeiro, Cortoni Calia, Leandro, Gonçalves, Marcus Vinícius Magno, Vecino, Maria Cecilia Aragón De, Pimentel, Maria Lucia Vellutini, Ribeiro, Marlise De Castro, Boaventura, Mateus, Parolin, Mônica Koncke Fiuza, Melo, Renata Brant De Souza, Lázaro, Robson, Thomaz, Rodrigo Barbosa, Kleinpaul, Rodrigo, Dias, Ronaldo Maciel, Gomes, Sidney, Lucatto, Simone Abrante, Alves-Leon, Soniza Vieira, Fukuda, Thiago, Ribeiro, Taysa Alexandrino Gonsalves Jubé, Winckler, Thereza Cristina D’ávila, Fragoso, Yara Dadalti, Nascimento, Osvaldo José Moreira Do, Ferreira, Maria Lucia Brito, Mendes, Maria Fernanda, Brum, Doralina Guimarães, Glehn, Felipe Von, Pontifícia Universidade Católica Do Rio Grande Do Sul, Universidade Federal de Sergipe (UFS), Universidade Tiradentes, Universidade Estadual de Campinas (UNICAMP), Universidade Federal de São Paulo (UNIFESP), Universidade Federal de Minas Gerais (UFMG), Universidade de São Paulo (USP), Universidade Federal Do Amazonas, Universidade Federal do Paraná (UFPR), Hospital Sírio Libanês, Escola Bahiana de Medicina e Saúde Pública, Hospital Geral de Fortaleza, Clínica Nossa Senhora das Graças, Hospital Santa Marcelina, Santa Casa, Instituto de Infectologia Emílio Ribas, Fundação Centro Integrado de Apoio Ao Portador de Deficiência, Secretaria de Estado da Saúde, Universidade Federal do Rio de Janeiro (UFRJ), Hospital de Clínicas de Passo Fundo, Universidade Federal de Goiás (UFG), Universidade Estácio de Sá, Hospital São Francisco Na Providência de Deus, Universidade Federal Do Ceará, Associação Brasileira de Esclerose Múltipla, Universidade Federal Fluminense (UFF), Pontifícia Universidade Católica, Instituto de Neurologia de Curitiba, IAMSPE, Private Service, Universidade da Região de Joinville, Hospital Moinhos de Vento, Universidade Federal Ciências da Saúde de Porto Alegre, Faculdade de Medicina de Jundiaí, Hospital Israelita Albert Einstein, Hospital de Base Do Distrito Federal, Hospital Beneficiência Portuguesa, Hospital Regional de Vilhena, Universidade Federal Do Estado Do Rio de Janeiro, Hospital Universitário Prof. Edgar Santos, Universidade Metropolitana de Santos, Hospital da Restauração, Universidade Estadual Paulista (UNESP), and Universidade de Brasília (UnB)

Subjects
Vacinação, Multiple Sclerosis, Doenças Autoimunes Desmielinizantes do Sistema Nervoso Central, Neuromielite Óptica, SARS-CoV-2, Esclerose Múltipla, Vaccination, Neuromyelitis Optica, COVID-19, Demyelinating Autoimmune Diseases, CNS
Abstract

Made available in DSpace on 2022-04-29T08:46:09Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-11-01 The Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology (DCNI/ABN) and Brazilian Committee for Treatment and Research in Multiple Sclerosis and Neuroimmunological Diseases (BCTRIMS) provide recommendations in this document for vaccination of the population with demyelinating diseases of the central nervous system (CNS) against infections in general and against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19. We emphasize the seriousness of the current situation in view of the spread of COVID-19 in our country. Therefore, reference guides on vaccination for clinicians, patients, and public health authorities are particularly important to prevent some infectious diseases. The DCNI/ABN and BCTRIMS recommend that patients with CNS demyelinating diseases (e.g., MS and NMOSD) be continually monitored for updates to their vaccination schedule, especially at the beginning or before a change in treatment with a disease modifying drug (DMD). It is also important to note that vaccines are safe, and physicians should encourage their use in all patients. Clearly, special care should be taken when live attenuated viruses are involved. Finally, it is important for physicians to verify which DMD the patient is receiving and when the last dose was taken, as each drug may affect the induction of immune response differently. Pontifícia Universidade Católica Do Rio Grande Do Sul, RS Universidade Federal de Sergipe, SE Universidade Tiradentes, SE Universidade de Campinas Faculdade de Ciências Médicas, SP Universidade Federal de São Paulo Escola Paulista de Medicina, SP Universidade Federal de Minas Gerais, MG Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas, SP Universidade Federal Do Amazonas, AM Universidade Federal Do Paraná, PR Hospital Sírio Libanês, SP Escola Bahiana de Medicina e Saúde Pública, BA Hospital Geral de Fortaleza, CE Clínica Nossa Senhora das Graças, MS Hospital Santa Marcelina, SP Santa Casa, MG Instituto de Infectologia Emílio Ribas, SP Fundação Centro Integrado de Apoio Ao Portador de Deficiência, PB Secretaria de Estado da Saúde, DF Universidade Federal Do Rio de Janeiro, RJ Santa Casa, PR Hospital de Clínicas de Passo Fundo, RS Universidade Federal de Goiás, GO Universidade Estácio de Sá, RJ Hospital São Francisco Na Providência de Deus, RJ Universidade Federal Do Ceará, CE Associação Brasileira de Esclerose Múltipla, SP Santa Casa, SP Universidade Federal Fluminense, RJ Pontifícia Universidade Católica, SP Instituto de Neurologia de Curitiba, PR IAMSPE, SP Private Service, SP Universidade da Região de Joinville, SC Hospital Moinhos de Vento, RS Santa Casa, RJ Universidade Federal Ciências da Saúde de Porto Alegre, RS Faculdade de Medicina de Jundiaí, SP Hospital Israelita Albert Einstein, SP Hospital de Base Do Distrito Federal, DF Hospital Beneficiência Portuguesa, SP Hospital Regional de Vilhena, RO Universidade Federal Do Estado Do Rio de Janeiro, RJ Hospital Universitário Prof. Edgar Santos, BA Universidade Metropolitana de Santos, SP Hospital da Restauração, PE Universidade Estadual Paulista Faculdade de Medicina de Botucatu, SP Universidade de Brasília Faculdade de Medicina, DF Universidade Estadual Paulista Faculdade de Medicina de Botucatu, SP

Published
2021

44. Neuromyelitis optica spectrum disorders: a review with a focus on children and adolescents.

Author

Barbosa Paolilo, Renata, Albino da Paz, José, Apóstolos-Pereira, Samira Luisa, de Medeiros Rimkus, Carolina, Callegaro, Dagoberto, and Kazutoshi Sato, Douglas

Abstract

Copyright of Arquivos de Neuro-Psiquiatria is the property of Thieme Medical Publishing Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2023
Full Text
View/download PDF

45. Recommendations by the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology (DCNI/ABN) and the Brazilian Committee for Treatment and Research in Multiple Sclerosis and Neuroimmunological Diseases (BCTRIMS) on vaccination in general and specifically against SARS-CoV-2 for patients with demyelinating diseases of the central nervous system

Author

Becker, Jefferson, primary, Ferreira, Lis Campos, additional, Damasceno, Alfredo, additional, Bichuetti, Denis Bernardi, additional, Christo, Paulo Pereira, additional, Callegaro, Dagoberto, additional, Peixoto, Marco Aurélio Lana, additional, Sousa, Nise Alessandra De Carvalho, additional, Almeida, Sérgio Monteiro De, additional, Adoni, Tarso, additional, Santiago-Amaral, Juliana, additional, Junqueira, Thiago, additional, Pereira, Samira Luisa Apóstolos, additional, Gomes, Ana Beatriz Ayroza Galvão Ribeiro, additional, Pitombeira, Milena, additional, Paolilo, Renata Barbosa, additional, Grzesiuk, Anderson Kuntz, additional, Piccolo, Ana Claudia, additional, D´Almeida, José Arthur Costa, additional, Gomes Neto, Antonio Pereira, additional, Oliveira, Augusto Cesar Penalva De, additional, Oliveira, Bianca Santos De, additional, Tauil, Carlos Bernardo, additional, Vasconcelos, Claudia Ferreira, additional, Kaimen-Maciel, Damacio, additional, Varela, Daniel, additional, Diniz, Denise Sisterolli, additional, Oliveira, Enedina Maria Lobato De, additional, Malfetano, Fabiola Rachid, additional, Borges, Fernando Elias, additional, Figueira, Fernando Faria Andrade, additional, Gondim, Francisco De Assis Aquino, additional, Passos, Giordani Rodrigues Dos, additional, Silva, Guilherme Diogo, additional, Olival, Guilherme Sciascia Do, additional, Santos, Gutemberg Augusto Cruz Dos, additional, Ruocco, Heloisa Helena, additional, Sato, Henry Koiti, additional, Soares Neto, Herval Ribeiro, additional, Cortoni Calia, Leandro, additional, Gonçalves, Marcus Vinícius Magno, additional, Vecino, Maria Cecilia Aragón De, additional, Pimentel, Maria Lucia Vellutini, additional, Ribeiro, Marlise De Castro, additional, Boaventura, Mateus, additional, Parolin, Mônica Koncke Fiuza, additional, Melo, Renata Brant De Souza, additional, Lázaro, Robson, additional, Thomaz, Rodrigo Barbosa, additional, Kleinpaul, Rodrigo, additional, Dias, Ronaldo Maciel, additional, Gomes, Sidney, additional, Lucatto, Simone Abrante, additional, Alves-Leon, Soniza Vieira, additional, Fukuda, Thiago, additional, Ribeiro, Taysa Alexandrino Gonsalves Jubé, additional, Winckler, Thereza Cristina D’ávila, additional, Fragoso, Yara Dadalti, additional, Nascimento, Osvaldo José Moreira Do, additional, Ferreira, Maria Lucia Brito, additional, Mendes, Maria Fernanda, additional, Brum, Doralina Guimarães, additional, and Glehn, Felipe Von, additional

Published
2021
Full Text
View/download PDF

47. Consenso expandido do BCTRIMS para o tratamento da esclerose múltipla: III. Diretrizes baseadas em evidências e recomendações

Author

Lana-Peixoto Marco Aurélio, Callegaro Dagoberto, Moreira Marcos Aurélio, Campos Gilberto Belisário, Marchiori Paulo Eurípedes, Gabbai Alberto Alain, Bacheschi Luiz Alberto, Arruda Walter Oleschko, Gama Paulo Diniz da, Melo Aílton Souza, Rocha Fernando Coronetti Gomes da, Lino Angelina Maria Martins, Ferreira Maria Lúcia Brito, and Ataíde Júnior Luiz

Subjects
esclerose múltipla, tratamento, recomendações, imunointervenção, Neurosciences. Biological psychiatry. Neuropsychiatry, RC321-571
Abstract

Em razão dos avanços no conhecimento da esclerose múltipla (EM), dos novos critérios diagnósticos e ensaios terapêuticos publicados, a atualização e expansão das diretrizes para orientação do neurologista brasileiro em relação ao tratamento da EM se tornam necessárias. O Consenso Expandido do BCTRIMS enfatiza a individualização do tratamento a critério do neurologista, e a necessidade de informação do paciente quanto aos potenciais benefícios e riscos das drogas, assim como do Consentimento Informado e compromisso de realização de controles periódicos. Na ausência de evidências científicas favorecendo uma determinada droga o médico deve considerar o custo diferencial dos imunomoduladores ao fazer sua opção terapêutica. As várias situações clínicas e os diferentes agentes modificadores da doença, assim como as outras intervenções terapêuticas de eficácia no tratamento são consideradas à luz das classes de evidências científicas e dos tipos de recomendação, aceitos pela comunidade científica internacional. O Consenso Expandido do BCTRIMS pode servir de modelo para outros países em desenvolvimento.

Published
2002

48. Reducing infection risk in multiple sclerosis and neuromyelitis optica spectrum disorders: a Brazilian reference center’s approach.

Author

Ayroza Galvão Ribeiro Gomes, Ana Beatriz, Bueno Feo, Lucas, Diogo Silva, Guilherme, Diniz Disserol, Caio César, Barbosa Paolilo, Renata, Nazareth Lara, Amanda, Coracini Tonácio, Adriana, Fernanda Mendes, Maria, Apóstolos Pereira, Samira Luísa, and Callegaro, Dagoberto

Abstract

Copyright of Arquivos de Neuro-Psiquiatria is the property of Thieme Medical Publishing Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results